Last update 16 May 2025

Radiolabeled DTPA-adenosylcobalamin(University of Minnesota)

Overview

Basic Info

Drug Type
Diagnostic radiopharmaceuticals, Radionuclide Drug Conjugates (RDC)
Synonyms
111-IN DAC
Target-
Action
enhancers
Mechanism
SPECT(Single-photon emission-computed tomography enhancers)
Therapeutic Areas
NeoplasmsNervous System DiseasesRespiratory Diseases+ [1]
Active Indication-
Inactive Indication
Brain CancerBreast CancerLung Cancer+ [3]
Originator Organization
University of MinnesotaUniversity of Minnesota
Active Organization-
Inactive Organization
University of MinnesotaUniversity of MinnesotaCopharos, Inc.
License Organization-
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

2
Clinical Trials associated with Radiolabeled DTPA-adenosylcobalamin(University of Minnesota)
NCT00040560
/ Unknown statusPhase 1
Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer
NCT00040430
/ Unknown statusPhase 1
Study of 111In-DAC as a Medical Imaging Agent for the Detection of Breast Cancer
100 Clinical Results associated with Radiolabeled DTPA-adenosylcobalamin(University of Minnesota)
Login to view more data
100 Translational Medicine associated with Radiolabeled DTPA-adenosylcobalamin(University of Minnesota)
Login to view more data
100 Patents (Medical) associated with Radiolabeled DTPA-adenosylcobalamin(University of Minnesota)
Login to view more data
100 Deals associated with Radiolabeled DTPA-adenosylcobalamin(University of Minnesota)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic Lung CancerPhase 1
United States
Copharos, Inc.
02 Jul 2002
Neoplasm MetastasisPhase 1
United States
Copharos, Inc.
02 Jul 2002
Non-Small Cell Lung CancerPhase 1
United States
Copharos, Inc.
02 Jul 2002
Brain CancerPhase 1
United States
Copharos, Inc.
02 Jul 2002
Breast CancerPhase 1
United States
Copharos, Inc.
28 Jun 2002
Lung CancerPhase 1-
University of MinnesotaUniversity of Minnesota
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free